 He has been an external reviewer of multiple NRC reports, including “Plan for the International Space Station,” “Future Biotechnology Research on the International Space Station,” "Assessment of Directions in Microgravity and Physical Sciences Research at NASA", and “The Astrophysical Context of Life.”

Ingber also has served as a consultant to numerous companies in the pharmaceutical, biotechnology, and cosmetics industries, including Merck, Roche, Astrazeneca, Biogen, Chanel, and L’Oreal, among others.He currently chairs the Scientific Advisory Boards of Emulate, Inc. and Boa Biomedical, Inc.He is an advisory board member for "Integrative Biology".